Steve D. Weinstein
Director/Board Member at Viamet Pharmaceuticals Corp.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
David C. Plough | M | - |
Portaero, Inc.
Portaero, Inc. Medical DistributorsDistribution Services Portaero, Inc. develops and manufactures medical devices. The company was founded on May 11, 2007 and is headquartered in Menlo Park, CA. | - |
Tobias Zutz | M | - |
Gregor Diagnostics, Inc.
Gregor Diagnostics, Inc. Medical SpecialtiesHealth Technology Gregor Diagnostics, Inc. develops and manufactures molecular diagnostics screening tests for prostate cancer. It provides proprietary system to maintain biomarker stability in the seminal fluid. The company was founded by Tobias Zutz in February 2016 and is headquartered in Madison, WI. | 8 years |
Robert J. Schotzinger | M | 63 |
Viamet Pharmaceuticals Corp.
Viamet Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Viamet Pharmaceuticals Corp. engages in the discovery, development, and commercialization of novel pharmaceuticals based on its proprietary metalloenzyme chemistry and biology technology platform. Its clinical portfolio includes novel agents to treat chronic and life threatening fungal infections. Its products include VT-1161, an oral agent that treats onychomycosis; VT-1129, which treats cryptococcal meningitis; and VT-1598, that treats coccidioidomycosis. The company was founded by Herbert Holden Thorp and Thomas V. O'Halloran in December 2011 and is headquartered in Durham, NC. | 13 years |
Jeffrey Edwards | M | 63 |
Viamet Pharmaceuticals Corp.
Viamet Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Viamet Pharmaceuticals Corp. engages in the discovery, development, and commercialization of novel pharmaceuticals based on its proprietary metalloenzyme chemistry and biology technology platform. Its clinical portfolio includes novel agents to treat chronic and life threatening fungal infections. Its products include VT-1161, an oral agent that treats onychomycosis; VT-1129, which treats cryptococcal meningitis; and VT-1598, that treats coccidioidomycosis. The company was founded by Herbert Holden Thorp and Thomas V. O'Halloran in December 2011 and is headquartered in Durham, NC. | - |
Ali R. Rezai | M | - |
Autonomic Technologies, Inc.
Autonomic Technologies, Inc. Electronic Equipment/InstrumentsElectronic Technology Autonomic Technologies, Inc. develops and commercializes innovative therapies for the treatment of severe headache. Its product, the ATI Neurostimulation System, is used for the treatment of acute pain of cluster headache. The company was founded in 2007 and is headquartered in Redwood City, CA. | - |
Andrew von Eschenbach | M | 82 |
Viamet Pharmaceuticals Corp.
Viamet Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Viamet Pharmaceuticals Corp. engages in the discovery, development, and commercialization of novel pharmaceuticals based on its proprietary metalloenzyme chemistry and biology technology platform. Its clinical portfolio includes novel agents to treat chronic and life threatening fungal infections. Its products include VT-1161, an oral agent that treats onychomycosis; VT-1129, which treats cryptococcal meningitis; and VT-1598, that treats coccidioidomycosis. The company was founded by Herbert Holden Thorp and Thomas V. O'Halloran in December 2011 and is headquartered in Durham, NC. | 13 years |
James E. Muller | M | 81 |
SpectraWAVE, Inc.
SpectraWAVE, Inc. Medical SpecialtiesHealth Technology Spectrawave, Inc. provides medical devices. The company is headquartered in Waltham, MA. | 7 years |
Dana Mead | M | 64 |
Autonomic Technologies, Inc.
Autonomic Technologies, Inc. Electronic Equipment/InstrumentsElectronic Technology Autonomic Technologies, Inc. develops and commercializes innovative therapies for the treatment of severe headache. Its product, the ATI Neurostimulation System, is used for the treatment of acute pain of cluster headache. The company was founded in 2007 and is headquartered in Redwood City, CA. | - |
Michael Joseph Partsch | M | - |
Gregor Diagnostics, Inc.
Gregor Diagnostics, Inc. Medical SpecialtiesHealth Technology Gregor Diagnostics, Inc. develops and manufactures molecular diagnostics screening tests for prostate cancer. It provides proprietary system to maintain biomarker stability in the seminal fluid. The company was founded by Tobias Zutz in February 2016 and is headquartered in Madison, WI. | - |
Eman Namati | M | - |
SpectraWAVE, Inc.
SpectraWAVE, Inc. Medical SpecialtiesHealth Technology Spectrawave, Inc. provides medical devices. The company is headquartered in Waltham, MA. | 4 years |
Adrian Howd | M | 52 |
Viamet Pharmaceuticals Corp.
Viamet Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Viamet Pharmaceuticals Corp. engages in the discovery, development, and commercialization of novel pharmaceuticals based on its proprietary metalloenzyme chemistry and biology technology platform. Its clinical portfolio includes novel agents to treat chronic and life threatening fungal infections. Its products include VT-1161, an oral agent that treats onychomycosis; VT-1129, which treats cryptococcal meningitis; and VT-1598, that treats coccidioidomycosis. The company was founded by Herbert Holden Thorp and Thomas V. O'Halloran in December 2011 and is headquartered in Durham, NC. | - |
S. Torres | M | 61 |
Viamet Pharmaceuticals Corp.
Viamet Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Viamet Pharmaceuticals Corp. engages in the discovery, development, and commercialization of novel pharmaceuticals based on its proprietary metalloenzyme chemistry and biology technology platform. Its clinical portfolio includes novel agents to treat chronic and life threatening fungal infections. Its products include VT-1161, an oral agent that treats onychomycosis; VT-1129, which treats cryptococcal meningitis; and VT-1598, that treats coccidioidomycosis. The company was founded by Herbert Holden Thorp and Thomas V. O'Halloran in December 2011 and is headquartered in Durham, NC. | 13 years |
Philip R. Tracy | M | 81 |
Viamet Pharmaceuticals Corp.
Viamet Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Viamet Pharmaceuticals Corp. engages in the discovery, development, and commercialization of novel pharmaceuticals based on its proprietary metalloenzyme chemistry and biology technology platform. Its clinical portfolio includes novel agents to treat chronic and life threatening fungal infections. Its products include VT-1161, an oral agent that treats onychomycosis; VT-1129, which treats cryptococcal meningitis; and VT-1598, that treats coccidioidomycosis. The company was founded by Herbert Holden Thorp and Thomas V. O'Halloran in December 2011 and is headquartered in Durham, NC. | 9 years |
David Morris | M | - |
Novartis Venture Funds (USA)
Novartis Venture Funds (USA) Investment ManagersFinance Founded in 1996, Novartis Venture Funds (USA) is a venture capital firm located in Cambridge, Massachusetts. The firm is a subsidiary of Switzerland-based Novartis Venture Funds and their ultimate parent is Novartis AG, a Switzerland-based company that engages in the research, development, manufacturing and marketing of healthcare products. Novartis Venture Funds manages the Bermuda domiciled biotechnology venture fund, Novartis BioVentures Ltd | 8 years |
John L Faul | M | - |
ROX Medical, Inc.
ROX Medical, Inc. Medical SpecialtiesHealth Technology ROX Medical, Inc. manufactures medical ultrasonic scanning devices. It offers ROX Coupler that is intended for use in patients with treatment resistant hypertension to lower blood pressure by reducing peripheral vascular resistance and improving vascular compliance; and in patients with chronic obstructive pulmonary disease to improve breathing, reduce symptoms of chronic bronchitis, and improve exercise tolerance. The company was founded by Rodney Brenneman and John Faul in 2004 and is headquartered in San Clemente, CA. | - |
Lauren Tyra | M | - |
Gregor Diagnostics, Inc.
Gregor Diagnostics, Inc. Medical SpecialtiesHealth Technology Gregor Diagnostics, Inc. develops and manufactures molecular diagnostics screening tests for prostate cancer. It provides proprietary system to maintain biomarker stability in the seminal fluid. The company was founded by Tobias Zutz in February 2016 and is headquartered in Madison, WI. | - |
Farzad Parsaie | M | 64 |
SpectraWAVE, Inc.
SpectraWAVE, Inc. Medical SpecialtiesHealth Technology Spectrawave, Inc. provides medical devices. The company is headquartered in Waltham, MA. | 3 years |
Charles Simonton | M | - |
SpectraWAVE, Inc.
SpectraWAVE, Inc. Medical SpecialtiesHealth Technology Spectrawave, Inc. provides medical devices. The company is headquartered in Waltham, MA. | - |
Guillermo Tearney | M | - |
SpectraWAVE, Inc.
SpectraWAVE, Inc. Medical SpecialtiesHealth Technology Spectrawave, Inc. provides medical devices. The company is headquartered in Waltham, MA. | - |
Michal Silverberg | F | 48 |
Novartis Venture Funds (USA)
Novartis Venture Funds (USA) Investment ManagersFinance Founded in 1996, Novartis Venture Funds (USA) is a venture capital firm located in Cambridge, Massachusetts. The firm is a subsidiary of Switzerland-based Novartis Venture Funds and their ultimate parent is Novartis AG, a Switzerland-based company that engages in the research, development, manufacturing and marketing of healthcare products. Novartis Venture Funds manages the Bermuda domiciled biotechnology venture fund, Novartis BioVentures Ltd | 7 years |
Sundu Brahmasandra | M | - |
Gregor Diagnostics, Inc.
Gregor Diagnostics, Inc. Medical SpecialtiesHealth Technology Gregor Diagnostics, Inc. develops and manufactures molecular diagnostics screening tests for prostate cancer. It provides proprietary system to maintain biomarker stability in the seminal fluid. The company was founded by Tobias Zutz in February 2016 and is headquartered in Madison, WI. | 2 years |
Eric Swanson | M | - |
SpectraWAVE, Inc.
SpectraWAVE, Inc. Medical SpecialtiesHealth Technology Spectrawave, Inc. provides medical devices. The company is headquartered in Waltham, MA. | - |
Peter Balmforth | M | - |
ROX Medical, Inc.
ROX Medical, Inc. Medical SpecialtiesHealth Technology ROX Medical, Inc. manufactures medical ultrasonic scanning devices. It offers ROX Coupler that is intended for use in patients with treatment resistant hypertension to lower blood pressure by reducing peripheral vascular resistance and improving vascular compliance; and in patients with chronic obstructive pulmonary disease to improve breathing, reduce symptoms of chronic bronchitis, and improve exercise tolerance. The company was founded by Rodney Brenneman and John Faul in 2004 and is headquartered in San Clemente, CA. | - |
Ian G. Welsford | M | - |
Autonomic Technologies, Inc.
Autonomic Technologies, Inc. Electronic Equipment/InstrumentsElectronic Technology Autonomic Technologies, Inc. develops and commercializes innovative therapies for the treatment of severe headache. Its product, the ATI Neurostimulation System, is used for the treatment of acute pain of cluster headache. The company was founded in 2007 and is headquartered in Redwood City, CA. | - |
David McIntyre | M | 53 |
ROX Medical, Inc.
ROX Medical, Inc. Medical SpecialtiesHealth Technology ROX Medical, Inc. manufactures medical ultrasonic scanning devices. It offers ROX Coupler that is intended for use in patients with treatment resistant hypertension to lower blood pressure by reducing peripheral vascular resistance and improving vascular compliance; and in patients with chronic obstructive pulmonary disease to improve breathing, reduce symptoms of chronic bronchitis, and improve exercise tolerance. The company was founded by Rodney Brenneman and John Faul in 2004 and is headquartered in San Clemente, CA. | - |
John Gilbert | M | - |
Visiogen, Inc.
Visiogen, Inc. Medical SpecialtiesHealth Technology Visiogen, Inc. develops products for cataract and refractive patients. It offers synchrony dual-optic accommodating intraocular lens and pre-loaded injector, which provide distance, intermediate, and near vision to presbyopic cataract patients. The company was founded on March 19, 2001 and is headquartered in Abbott Park, IL. | - |
Kim Kamdar | M | 56 |
ROX Medical, Inc.
ROX Medical, Inc. Medical SpecialtiesHealth Technology ROX Medical, Inc. manufactures medical ultrasonic scanning devices. It offers ROX Coupler that is intended for use in patients with treatment resistant hypertension to lower blood pressure by reducing peripheral vascular resistance and improving vascular compliance; and in patients with chronic obstructive pulmonary disease to improve breathing, reduce symptoms of chronic bronchitis, and improve exercise tolerance. The company was founded by Rodney Brenneman and John Faul in 2004 and is headquartered in San Clemente, CA. | - |
Martinus Adrianus van Osch | M | - |
Autonomic Technologies, Inc.
Autonomic Technologies, Inc. Electronic Equipment/InstrumentsElectronic Technology Autonomic Technologies, Inc. develops and commercializes innovative therapies for the treatment of severe headache. Its product, the ATI Neurostimulation System, is used for the treatment of acute pain of cluster headache. The company was founded in 2007 and is headquartered in Redwood City, CA. | - |
Douglas Reed | M | 70 |
Viamet Pharmaceuticals Corp.
Viamet Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Viamet Pharmaceuticals Corp. engages in the discovery, development, and commercialization of novel pharmaceuticals based on its proprietary metalloenzyme chemistry and biology technology platform. Its clinical portfolio includes novel agents to treat chronic and life threatening fungal infections. Its products include VT-1161, an oral agent that treats onychomycosis; VT-1129, which treats cryptococcal meningitis; and VT-1598, that treats coccidioidomycosis. The company was founded by Herbert Holden Thorp and Thomas V. O'Halloran in December 2011 and is headquartered in Durham, NC. | 13 years |
Kristopher Wood | M | 52 |
Viamet Pharmaceuticals Corp.
Viamet Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Viamet Pharmaceuticals Corp. engages in the discovery, development, and commercialization of novel pharmaceuticals based on its proprietary metalloenzyme chemistry and biology technology platform. Its clinical portfolio includes novel agents to treat chronic and life threatening fungal infections. Its products include VT-1161, an oral agent that treats onychomycosis; VT-1129, which treats cryptococcal meningitis; and VT-1598, that treats coccidioidomycosis. The company was founded by Herbert Holden Thorp and Thomas V. O'Halloran in December 2011 and is headquartered in Durham, NC. | - |
Ross Jaffe | M | 65 |
Portaero, Inc.
Portaero, Inc. Medical DistributorsDistribution Services Portaero, Inc. develops and manufactures medical devices. The company was founded on May 11, 2007 and is headquartered in Menlo Park, CA. | - |
Guido Neels | M | 75 |
ROX Medical, Inc.
ROX Medical, Inc. Medical SpecialtiesHealth Technology ROX Medical, Inc. manufactures medical ultrasonic scanning devices. It offers ROX Coupler that is intended for use in patients with treatment resistant hypertension to lower blood pressure by reducing peripheral vascular resistance and improving vascular compliance; and in patients with chronic obstructive pulmonary disease to improve breathing, reduce symptoms of chronic bronchitis, and improve exercise tolerance. The company was founded by Rodney Brenneman and John Faul in 2004 and is headquartered in San Clemente, CA. | - |
Andrew Firlik | M | - |
Visiogen, Inc.
Visiogen, Inc. Medical SpecialtiesHealth Technology Visiogen, Inc. develops products for cataract and refractive patients. It offers synchrony dual-optic accommodating intraocular lens and pre-loaded injector, which provide distance, intermediate, and near vision to presbyopic cataract patients. The company was founded on March 19, 2001 and is headquartered in Abbott Park, IL. | - |
Roger J. Quy | M | - |
Visiogen, Inc.
Visiogen, Inc. Medical SpecialtiesHealth Technology Visiogen, Inc. develops products for cataract and refractive patients. It offers synchrony dual-optic accommodating intraocular lens and pre-loaded injector, which provide distance, intermediate, and near vision to presbyopic cataract patients. The company was founded on March 19, 2001 and is headquartered in Abbott Park, IL. | - |
Maribel Gonzalez | F | - |
Medtronic Ablation Frontiers LLC
Medtronic Ablation Frontiers LLC Medical SpecialtiesHealth Technology Medtronic Ablation Frontiers LLC provides technology solutions for cardiac therapy to cure heart arrhythmias focusing on a trial fibrillation. The firm focuses in the treatment of ablation therapy. The company was founded in 2004 and is headquartered in Carlsbad, CA. | 18 years |
Richard Yu-Tsang Lin | M | - |
Visiogen, Inc.
Visiogen, Inc. Medical SpecialtiesHealth Technology Visiogen, Inc. develops products for cataract and refractive patients. It offers synchrony dual-optic accommodating intraocular lens and pre-loaded injector, which provide distance, intermediate, and near vision to presbyopic cataract patients. The company was founded on March 19, 2001 and is headquartered in Abbott Park, IL. | - |
Alexander G. Asam | M | 58 |
Autonomic Technologies, Inc.
Autonomic Technologies, Inc. Electronic Equipment/InstrumentsElectronic Technology Autonomic Technologies, Inc. develops and commercializes innovative therapies for the treatment of severe headache. Its product, the ATI Neurostimulation System, is used for the treatment of acute pain of cluster headache. The company was founded in 2007 and is headquartered in Redwood City, CA. | - |
Sean Murphy | M | 71 |
Viamet Pharmaceuticals Corp.
Viamet Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Viamet Pharmaceuticals Corp. engages in the discovery, development, and commercialization of novel pharmaceuticals based on its proprietary metalloenzyme chemistry and biology technology platform. Its clinical portfolio includes novel agents to treat chronic and life threatening fungal infections. Its products include VT-1161, an oral agent that treats onychomycosis; VT-1129, which treats cryptococcal meningitis; and VT-1598, that treats coccidioidomycosis. The company was founded by Herbert Holden Thorp and Thomas V. O'Halloran in December 2011 and is headquartered in Durham, NC. | 7 years |
Rodney D. Altman | M | 61 |
Visiogen, Inc.
Visiogen, Inc. Medical SpecialtiesHealth Technology Visiogen, Inc. develops products for cataract and refractive patients. It offers synchrony dual-optic accommodating intraocular lens and pre-loaded injector, which provide distance, intermediate, and near vision to presbyopic cataract patients. The company was founded on March 19, 2001 and is headquartered in Abbott Park, IL. | - |
Reza Zadno | M | 69 |
Autonomic Technologies, Inc.
Autonomic Technologies, Inc. Electronic Equipment/InstrumentsElectronic Technology Autonomic Technologies, Inc. develops and commercializes innovative therapies for the treatment of severe headache. Its product, the ATI Neurostimulation System, is used for the treatment of acute pain of cluster headache. The company was founded in 2007 and is headquartered in Redwood City, CA. | - |
Sigrid van Bladel | M | - |
Autonomic Technologies, Inc.
Autonomic Technologies, Inc. Electronic Equipment/InstrumentsElectronic Technology Autonomic Technologies, Inc. develops and commercializes innovative therapies for the treatment of severe headache. Its product, the ATI Neurostimulation System, is used for the treatment of acute pain of cluster headache. The company was founded in 2007 and is headquartered in Redwood City, CA. | - |
Jerald Cox | M | - |
Medtronic Ablation Frontiers LLC
Medtronic Ablation Frontiers LLC Medical SpecialtiesHealth Technology Medtronic Ablation Frontiers LLC provides technology solutions for cardiac therapy to cure heart arrhythmias focusing on a trial fibrillation. The firm focuses in the treatment of ablation therapy. The company was founded in 2004 and is headquartered in Carlsbad, CA. | 18 years |
Rebecca Seidel | F | - |
Medtronic Ablation Frontiers LLC
Medtronic Ablation Frontiers LLC Medical SpecialtiesHealth Technology Medtronic Ablation Frontiers LLC provides technology solutions for cardiac therapy to cure heart arrhythmias focusing on a trial fibrillation. The firm focuses in the treatment of ablation therapy. The company was founded in 2004 and is headquartered in Carlsbad, CA. | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
John Clem | M | 52 |
Stephen M. Ross School of Business
| 2 years |
Juliette Audet | F | 38 |
Novartis Venture Funds (USA)
Novartis Venture Funds (USA) Investment ManagersFinance Founded in 1996, Novartis Venture Funds (USA) is a venture capital firm located in Cambridge, Massachusetts. The firm is a subsidiary of Switzerland-based Novartis Venture Funds and their ultimate parent is Novartis AG, a Switzerland-based company that engages in the research, development, manufacturing and marketing of healthcare products. Novartis Venture Funds manages the Bermuda domiciled biotechnology venture fund, Novartis BioVentures Ltd | 1 years |
Veronica Keaveney | F | - |
Novartis Venture Funds (USA)
Novartis Venture Funds (USA) Investment ManagersFinance Founded in 1996, Novartis Venture Funds (USA) is a venture capital firm located in Cambridge, Massachusetts. The firm is a subsidiary of Switzerland-based Novartis Venture Funds and their ultimate parent is Novartis AG, a Switzerland-based company that engages in the research, development, manufacturing and marketing of healthcare products. Novartis Venture Funds manages the Bermuda domiciled biotechnology venture fund, Novartis BioVentures Ltd | 1 years |
Christine Brennan | M | 56 |
Novartis Venture Funds (USA)
Novartis Venture Funds (USA) Investment ManagersFinance Founded in 1996, Novartis Venture Funds (USA) is a venture capital firm located in Cambridge, Massachusetts. The firm is a subsidiary of Switzerland-based Novartis Venture Funds and their ultimate parent is Novartis AG, a Switzerland-based company that engages in the research, development, manufacturing and marketing of healthcare products. Novartis Venture Funds manages the Bermuda domiciled biotechnology venture fund, Novartis BioVentures Ltd | 4 years |
Dave Paborsky | M | - |
Stephen M. Ross School of Business
| 3 years |
Travis Sessions | M | - |
Stephen M. Ross School of Business
| 2 years |
Julian Evans | M | 54 |
Stephen M. Ross School of Business
| 2 years |
Adam Pollitzer | M | 45 |
Stephen M. Ross School of Business
| 4 years |
Jennifer Niemann | F | 55 |
Stephen M. Ross School of Business
| 2 years |
Kuldeep Malkani | M | 48 |
Stephen M. Ross School of Business
| 4 years |
Paul Taheri | M | - |
Stephen M. Ross School of Business
| 2 years |
Ben Ellis | M | - |
Stephen M. Ross School of Business
| 4 years |
Shao-Ning Huang | F | - |
Stephen M. Ross School of Business
| 1 years |
Michelle St. Jacques | F | 46 |
Stephen M. Ross School of Business
| 4 years |
Linda Mok | F | - |
Stephen M. Ross School of Business
| 3 years |
Mary A. Sagripanti | F | 58 |
Stephen M. Ross School of Business
| 2 years |
Mike Reichenbach | M | - |
Stephen M. Ross School of Business
| 2 years |
Mike Shang | M | - |
Stephen M. Ross School of Business
| 4 years |
Joseph Chang | M | - |
Stephen M. Ross School of Business
| 4 years |
Bill Martin | M | - |
Stephen M. Ross School of Business
| 2 years |
Amir Rubin | M | 54 |
Stephen M. Ross School of Business
| 3 years |
Derek Saint Izuel | M | - |
Stephen M. Ross School of Business
| 2 years |
Charlie E. Booth | M | - |
Stephen M. Ross School of Business
| 4 years |
Marshall Earl Reid | M | - |
Stephen M. Ross School of Business
| 2 years |
Dan Ward | M | - |
Stephen M. Ross School of Business
| 3 years |
Giovanni A. Ferrara | M | 55 |
Novartis Venture Funds (USA)
Novartis Venture Funds (USA) Investment ManagersFinance Founded in 1996, Novartis Venture Funds (USA) is a venture capital firm located in Cambridge, Massachusetts. The firm is a subsidiary of Switzerland-based Novartis Venture Funds and their ultimate parent is Novartis AG, a Switzerland-based company that engages in the research, development, manufacturing and marketing of healthcare products. Novartis Venture Funds manages the Bermuda domiciled biotechnology venture fund, Novartis BioVentures Ltd | 7 years |
Steve Linden | M | - |
Stephen M. Ross School of Business
| 4 years |
Gordon Cervenka | M | - |
Stephen M. Ross School of Business
| 2 years |
Henry Skinner | M | 60 |
Novartis Venture Funds (USA)
Novartis Venture Funds (USA) Investment ManagersFinance Founded in 1996, Novartis Venture Funds (USA) is a venture capital firm located in Cambridge, Massachusetts. The firm is a subsidiary of Switzerland-based Novartis Venture Funds and their ultimate parent is Novartis AG, a Switzerland-based company that engages in the research, development, manufacturing and marketing of healthcare products. Novartis Venture Funds manages the Bermuda domiciled biotechnology venture fund, Novartis BioVentures Ltd | 9 years |
Amit P. Patel | M | - |
Stephen M. Ross School of Business
| 4 years |
Josh Strauss | M | - |
Stephen M. Ross School of Business
| 2 years |
Tim Hartch | M | - |
Stephen M. Ross School of Business
| 3 years |
Trevor Mundel | M | - |
Novartis Venture Funds (USA)
Novartis Venture Funds (USA) Investment ManagersFinance Founded in 1996, Novartis Venture Funds (USA) is a venture capital firm located in Cambridge, Massachusetts. The firm is a subsidiary of Switzerland-based Novartis Venture Funds and their ultimate parent is Novartis AG, a Switzerland-based company that engages in the research, development, manufacturing and marketing of healthcare products. Novartis Venture Funds manages the Bermuda domiciled biotechnology venture fund, Novartis BioVentures Ltd | - |
David C. Friedman | M | 55 |
Stephen M. Ross School of Business
| 2 years |
Paul Tan | M | - |
Stephen M. Ross School of Business
| 4 years |
Todd B. Ernst | M | - |
Stephen M. Ross School of Business
| 2 years |
Tige Savage | M | 56 |
Stephen M. Ross School of Business
| 2 years |
Ryan Waddington | M | - |
Stephen M. Ross School of Business
| 2 years |
Juan Ignacio Rosado Gómez de la Torre | M | 55 |
Stephen M. Ross School of Business
| 4 years |
Lauren Silverman | M | 69 |
Novartis Venture Funds (USA)
Novartis Venture Funds (USA) Investment ManagersFinance Founded in 1996, Novartis Venture Funds (USA) is a venture capital firm located in Cambridge, Massachusetts. The firm is a subsidiary of Switzerland-based Novartis Venture Funds and their ultimate parent is Novartis AG, a Switzerland-based company that engages in the research, development, manufacturing and marketing of healthcare products. Novartis Venture Funds manages the Bermuda domiciled biotechnology venture fund, Novartis BioVentures Ltd | 10 years |
Kofi Bruce | M | 54 |
Stephen M. Ross School of Business
| 2 years |
John Cochran | M | - |
Stephen M. Ross School of Business
| 3 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 85 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Steve D. Weinstein
- Personal Network